* Somalogic Inc SLGC.OQ reported a quarterly adjusted loss
of 13
cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 15 cents per share.
* Revenue rose 44.7% to $20.47 million from a year ago;
analysts
expected $19.82 million.
* Somalogic Inc's reported EPS for the quarter was a loss
of 13
cents.
* The mean earnings estimate of analysts had risen by
about 6.1%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
* Somalogic Inc shares had fallen by 10.4% this quarter and
lost 17.5% so far this year.
* The company reported a quarterly loss of $24.77 million.
* Wall Street's median 12-month price target for Somalogic
Inc is
$6.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 14 at 09:37 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.15 -0.13 Beat
Mar. 31 2023 -0.22 -0.18 Beat
Dec. 31 2022 -0.21 -0.26 Missed
Sep. 30 2022 -0.20 -0.18 Beat